Xiaobin Wu sold $5.8M of ONC
President and COO at BeiGene, Ltd.. 16,009 shares at an average of $365.22, traded Nov 12, 2025, filed Nov 14, 2025.
Score components
- +20RolePresident
- +25Trade size$5.8M at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -12.8%, 3m -5.4%, 6m -19.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001739452-25-000005, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 12, 2025 | SOpen-market sale American Depositary Shares | -500 | $350.44 | $175k | 15,509 | Nov 14, 2025 |
| Nov 12, 2025 | SOpen-market sale American Depositary Shares | -3,240 | $351.41 | $1.1M | 12,269 | Nov 14, 2025 |
| Nov 12, 2025 | SOpen-market sale American Depositary Shares | -789 | $352.78 | $278k | 11,480 | Nov 14, 2025 |
| Nov 12, 2025 | SOpen-market sale American Depositary Shares | -251 | $354.20 | $89k | 11,229 | Nov 14, 2025 |
| Nov 12, 2025 | SOpen-market sale American Depositary Shares | -120 | $355.00 | $43k | 11,109 | Nov 14, 2025 |
| Nov 12, 2025 | SOpen-market sale American Depositary Shares | -100 | $357.43 | $36k | 11,009 | Nov 14, 2025 |
| Nov 12, 2025 | SOpen-market sale American Depositary Shares | -4,846 | $360.10 | $1.7M | 6,163 | Nov 14, 2025 |
| Nov 12, 2025 | SOpen-market sale American Depositary Shares | -154 | $362.07 | $56k | 6,009 | Nov 14, 2025 |
| Nov 13, 2025 | SOpen-market sale American Depositary Shares | -4,240 | $380.33 | $1.6M | 1,769 | Nov 14, 2025 |
| Nov 13, 2025 | SOpen-market sale American Depositary Shares | -1,769 | $381.05 | $674k | 0 | Nov 14, 2025 |
Related signals
Other insiders at BeiGene, Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 39Weak | BeiGene, Ltd. | Chan Henry Lee SVP, General Counsel | $418k 1,115 shares | -100% | |
| 33Weak | BeiGene, Ltd. | Xiaodong Wang director, other | $11M 31,028 shares | -100% | |
| 40Moderate | BeiGene, Ltd. | Xiaodong Wang director, other | $13M 38,287 shares | -527% | |
| 56Moderate | BeiGene, Ltd. | Titus B. Ball Principal Accounting Officer | $47k 132 shares | -100% | |
| 45Moderate | BeiGene, Ltd. | Xiaobin Wu President and COO | $106k 280 shares | -100% | |
| 39Weak | BeiGene, Ltd. | Chan Henry Lee SVP, General Counsel | $960k 2,666 shares | -100% | |
| 65Notable | BeiGene, Ltd. | John Oyler Chief Executive Officer | $86M 240,810 shares | -100% | |
| 72Notable | BeiGene, Ltd. | Aaron Rosenberg Chief Financial Officer | $362k 1,157 shares | -100% | |
| 65Notable | BeiGene, Ltd. | Chan Henry Lee SVP, General Counsel | $338k 1,044 shares | -100% | |
| 34Weak | BeiGene, Ltd. | Chan Henry Lee SVP, General Counsel | $542k 1,669 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.